Real-world outcomes of first- and second-generation tyrosine kinase inhibitors first-line in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer: A retrospective observational cohort study

The sequencing of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in patients with EGFR mutation-positive (EGFRm+) non-small cell lung cancer (NSCLC) remains a matter of controversy. This cohort study analyzed the overall survival (OS) and progression-free survival (PFS) of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Wei-Wei, Lin, Chen-Chun, Cheng, Ching-Yuan, Jiang, Jiunn-Song, Kao, Shang-Jyh, Yeh, Diana Yuwung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224855/
https://www.ncbi.nlm.nih.gov/pubmed/34166400
http://dx.doi.org/10.1371/journal.pone.0253335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224855/
https://www.ncbi.nlm.nih.gov/pubmed/34166400
http://dx.doi.org/10.1371/journal.pone.0253335

Ejemplares similares